Observational studyMedicine2019

IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype.

Feiya Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.